The FDA granted accelerated approval to enfortumab vedotin-ejfv for treatment of adults with locally advanced or metastatic urothelial cancer, the agent’s developers announced in a press release.The approval applies to use of enfortumab vedotin-ejfv (Padcev; Astellas, Seattle Genetics) by patients who previously received a PD-1/PD-L1 inhibitor and a platinum-containing chemotherapy before
Three risk assessment tools struggled to detect osteoporosis based on bone mineral density T-scores among women aged 50 to 64 years, researchers reported in a…
A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis,…
Newborns with congenital heart disease and their mothers may both face elevated risk for cancer compared with their counterparts not affected by congenital heart disease,…
A survey of musicians with breast cancer revealed more than one-quarter experienced difficulties with their musical endeavors during or after cancer treatment.In most cases, the…
Among children born in France, 83.1% had been prescribed a respiratory medication during the ages of 0 through 10 years, according to results published in…
SAN DIEGO — Results presented here showed health care descriptions created by ChatGPT were perceived to be accurate, authentic and believable by patients undergoing total…
SAN DIEGO — Results showed white patients were more likely to undergo total hip arthroplasty for displaced femoral neck fracture compared with historically underrepresented groups,…
A randomized phase 3 trial designed to compare an investigational combination with standard care for certain patients with advanced colorectal cancer failed to meet its…
SAN DIEGO — Results presented here showed repeat closed reduction for both bone forearm fractures in patients older than 8 years resulted in a higher…
Barclay Missen had resigned himself to hospice care.Missen, a 53-year-old from Chicago, got diagnosed with stage IV colorectal cancer in 2021.
